Press "Enter" to skip to content

Tag: SARS-CoV-2

RFK Jr says no COVID vaccines for healthy children, pregnant women

Today Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. made another sweeping change to the US vaccine landscape, saying the Centers for Disease Control and Prevention (CDC) has removed its recommendation of the COVID-19 vaccine for healthy children and pregnant women.

“I couldn’t be more pleased to announce that, as of today, the COVID vaccine for healthy children and healthy pregnant woman has been removed from the CDC recommended immunization schedule,” Kennedy said in a video message, flanked by Martin Makary, MD, MPH, commissioner of the Food and Drug Administration, and Jay Bhattacharya, MD, PhD, director of the National Institutes of Health.

The move comes just 1 week after the FDA announced—via an opinion piece in the New England Journal of Medicine—that the vaccine would now be offered only to adults 65 years and older or those with underlying conditions that made them vulnerable to severe COVID-19.

Today’s video message is short and direct but is already causing confusion, as pregnancy itself is considered a risk factor for severe COVID-19.

Comments closed

U.S. reports cases of new COVID variant NB.1.8.1 behind surge in China

The Centers for Disease Control and Prevention’s airport screening program has detected multiple cases of the new COVID-19 variant NB.1.8.1, which has been linked to a large surge of the virus in China.

Cases linked to the NB.1.8.1 variant have been reported in arriving international travelers at airports in California, Washington state, Virginia and the New York City area, according to records uploaded by the CDC’s airport testing partner Ginkgo Bioworks.

Details about the sequencing results, which were published in recent weeks on the GISAID, or Global Initiative on Sharing All Influenza Data, virus database, show the cases stem from travelers from a number of countries, including Japan, South Korea, France, Thailand, the Netherlands, Spain, Vietnam, China and Taiwan. The travelers were tested from April 22 through May 12, the records show.

Comments closed

The FDA’s misguided new Covid vaccine policy repeats past mistakes

The Food and Drug Administration is rewriting America’s Covid vaccine playbook — and not for the better. Its new guidance would trade the clarity and reach of our current vaccination strategy for a confusing age-based and risk-based framework that simply doesn’t fit the realities of Americans’ health. As a primary care physician who has spent years on the front lines of pandemic response, I see this as a step backward that ignores both the lessons of our past and the needs of our most vulnerable patients.

The FDA’s proposed framework eerily mirrors the segmentation we attempted in fall 2021 with Covid boosters. When boosters initially rolled out in September 2021, the FDA authorized them only for specific groups: adults 65 and older, those 18-64 with high-risk conditions, and those with occupational exposure risks.

The approach failed. As someone who had to explain these complex eligibility requirements to confused patients, I can attest to the chaos it created. This limited approach created tremendous confusion among health care providers and patients alike. Pharmacies and clinics struggled to verify eligibility, people misunderstood their risk category and, ultimately, many high-risk individuals who genuinely needed boosters never received them.

Comments closed

F.D.A. Approves Novavax Covid Vaccine With Stricter New Conditions

The Food and Drug Administration on Friday approved the Novavax Covid-19 vaccine, but only for older adults and for others over age 12 who have at least one medical condition that puts them at high risk from Covid.

Scientific advisers to the Centers for Disease Control and Prevention, who typically make decisions on who should get approved shots and when, have been debating whether to recommend Covid shots only to the most vulnerable Americans. The F.D.A.’s decision appeared to render at least part of their discussion moot.

The new restriction will sharply limit access to the Novavax vaccine for people under 65 who are in good health. It may leave Americans who do not have underlying conditions at risk if a more virulent version of the coronavirus were to emerge. It could also limit options for people who want the vaccine for a wide array of reasons, including to protect a vulnerable loved one.

Comments closed

Long COVID May Cause Long-Term Changes in the Heart and Lungs and May Lead to Cardiac and Pulmonary Diseases

Mount Sinai study suggests COVID-19 infection should be considered a risk factor for future cardiopulmonary conditions

New York, NY (May 6, 2025) — Patients suffering from long COVID may exhibit persistent inflammation in the heart and lungs for up to a year following SARS-CoV-2 infection—even when standard medical tests return normal results—potentially placing them at elevated risk for future cardiac and pulmonary conditions. These findings come from a new study conducted by researchers at the Icahn School of Medicine at Mount Sinai and published April 30, in the Journal of Nuclear Medicine.

The study, the largest of its kind using advanced PET/MRI imaging, discovered significant abnormalities in cardiovascular and pulmonary tissues, as well as altered levels of circulating immune-regulating proteins, in long COVID patients. These abnormalities could serve as early warning signs of diseases such as heart failure, valvular heart disease, and pulmonary hypertension.

Comments closed

VA study: Pfizer COVID booster 68% effective against hospitalization

A study published earlier this week in Nature Communications using claims data from the US Veterans Affairs (VA) Healthcare System finds protection from the 2024-25 Pfizer COVID-19 vaccine was 68%, 57%, and 56% against COVID-19–associated hospitalizations, emergency department and urgent care (ED/UC) visits, and outpatient visits, respectively.

However, the authors caution that uptake of the vaccine was extremely low—only 3.7% through November 2024—and the study did not assess waning effectiveness.

The study estimated early BNT162b2 KP.2 (2024-25 formulation) vaccine effectiveness (VE) against COVID-19 outcomes compared to not receiving the vaccine.

Comments closed

Ottawa: Contact councillors — save our wastewater monitoring!

📣 Let municipal councillors know you want funding for wastewater monitoring to continue

✉️ Send letters to municipal councillors in Ottawa to voice your support for wastewater monitoring. Use our online tool to send emails.

Why take action? The funding for Ottawa’s wastewater monitoring program is currently set to expire in September 2025. Wastewater monitoring is an essential public health tool that provides insights into the spread of SARS-CoV-2 and other viruses in Ottawa. We need an early warning system to inform everyone about the prevalence of SARS-CoV-2 subvariants, influenza, avian flu, RSV, mpox, and other viruses.

Comments closed

2 doses of COVID-19 vaccine recommended for Yukoners at higher risk of severe illness

In an April 24 press release, YG said it is acting on the advice of the Yukon’s chief medical officer of health, and the National Advisory Committee on Immunization.

Those who are eligible for the twice-per-year vaccination encompass multiple categories: people aged 6 months to 64 years who are moderately to severely immunocompromised due to an underlying condition or treatment; residents in long-term care homes and other congregate living settings for seniors; and adults 65 years or older.

Comments closed

Possible treatments for long COVID at the centre of new Western study

More than 300 patients across four continents are at the centre of a Western long COVID study, which hopes to find an effective treatment for those who struggle with long COVID.

The study will look to trial two anti-inflammatory medicines as potential treatments, and hopes to bring into view people who struggle with the disease outside of North America.

“Despite the global prevalence of long COVID, patients report different symptoms and their presentation can be influenced by where they happen to live,” said Dr. Douglas Fraser, professor at Western’s Schulich School of Medicine & Dentistry. “A study with global reach, tailored to examine each patient’s most severe symptoms, has the potential to bring hope to people well beyond Canada and the U.S.”

Comments closed

Novavax says its COVID-19 shot is on track for full FDA approval after delay

WASHINGTON (AP) — Novavax’s closely watched COVID-19 vaccine is on track for full approval after additional discussions with the Food and Drug Administration, the company said Wednesday.

The news sent company shares soaring more than 21% in morning trading and appeared to resolve concerns that Trump administration officials might be holding up a decision on the shot.

Comments closed

RFK Jr. eyes reversing CDC’s Covid-19 vaccine recommendation for children

HHS Secretary Robert F. Kennedy Jr. is weighing pulling the Covid-19 vaccine from the government’s list of recommended immunizations for children, two people familiar with the discussions told POLITICO.

The directive under consideration would remove the Covid shot from the childhood vaccine schedule maintained by the Centers for Disease Control and Prevention and widely used by physicians to guide vaccine distribution, marking Kennedy’s most significant move yet to shake up the nation’s vaccination practices.

Comments closed

Is Public Health Really Dead?

Local podcaster Daniella Barreto called her latest project Public Health Is Dead to capture her frustration with how leaders handled the COVID-19 pandemic.

“It seemed like all of these things we’re taught in school, like prevention being key and using evidence to make decisions, was thrown out the window,” Barreto told The Tyee. “Mask mandates were being taken away, people were increasingly getting long COVID, and I decided I needed to do something because people were not getting the information they needed.”

Launching the podcast in November 2024, Barreto used her background in public health, with a master of science in population public health from the University of British Columbia and a bachelor of science in health science from Simon Fraser University, to help explain what went wrong. So far she’s released five episodes and has many more in the works.

Comments closed

Manitoba rolling out COVID-19 spring vaccination campaign for high-risk groups

Manitoba is rolling out a vaccination campaign for those at the highest risk of developing serious outcomes from COVID-19, aiming to get people vaccinated before summer, when virus circulation might increase, the province says.

Between May 1 and June 30, the province will make additional COVID-19 vaccine doses available for people who have already had a dose since last fall, but meet specific criteria.

The extra doses will be available to anyone age 65 or older, Indigenous people over the age of 45, residents of long-term care homes, and anyone age six months or up who is moderately or severely immunocompromised.

Comments closed

WHO member states agree to landmark accord on future pandemic responses

Countries united under the World Health Organization on Wednesday agreed to a milestone accord on how to respond to future pandemics and avoid repeating the mistakes made during the Covid-19 crisis. The agreement comes despite US foreign aid cuts and possible tariffs on pharmaceuticals casting uncertainty over the talks.

Years of negotiations culminated early Wednesday with countries agreeing the text of a landmark accord on how to tackle future pandemics, aimed at avoiding a repeat of the mistakes made during the Covid-19 crisis.

After more than three years of talks and one last marathon session, weary delegates at the World Health Organization’s headquarters sealed the deal at around 2am (0000 GMT) Wednesday.

“Tonight marks a significant milestone in our shared journey towards a safer world,” WHO chief Tedros Adhanom Ghebreyesus said.

“The nations of the world made history in Geneva today.”

Comments closed

Seniors 75 and over invited to get COVID-19 vaccine

(Montreal) A COVID-19 vaccination campaign is launched this spring for people at risk of developing complications, Santé Québec announced on Monday.

Teams are currently deployed in the province’s long-term care homes, after which vaccination will be offered in private seniors’ residences (RPA) with a more vulnerable clientele.

In addition to CHSLDs and RPAs, seniors 75 years of age or older and people with immunodeficiency or dialysis are encouraged to go get their vaccine dose. This vaccination campaign also aims to reach people aged 65-74 who live with a chronic disease or in remote and isolated areas.

Non-targeted people aged 6 months and older can also receive the COVID-19 vaccine free of charge, says Santé Québec. If they have already been vaccinated, they should wait at least six months after their vaccine before receiving a new dose.

Comments closed

Is Covid Rewriting the Rules of Aging? Brain Decline Alarms Doctors

Five years after the pandemic’s start, millions of Americans are still struggling with long-lasting symptoms of Covid-19. Cognitive difficulties are among the most troubling and common symptoms in people both old and young.

These ailments can be severe enough to leave former professionals like Ken Todd unable to work and even diagnosed with a form of mild cognitive impairment.

Comments closed

Studies: 1 in 7 US working-age adults report long COVID, with heaviest burden on the poor

Nearly 1 in 7 working-age US adults had experienced long COVID by late 2023, and socially disadvantaged adults were over 150% more likely to have persistent symptoms, two new studies find.

Future public health, economic burdens

Yesterday in Communications Medicine, Daniel Kim, MD, DrPH, of Northeastern University, analyzed data from the US Census Bureau’s Household Pulse Survey from September and November 2022 and August to October 2023 on more than 375,000 US adults, including nearly 50,000 with self-reported long COVID.

Kim assessed sociodemographic and socioeconomic factors as predictors of long COVID; estimated the risk of unemployment, financial difficulties, and anxiety and depression among working-age adults (ages 18 to 64 years) and those currently experiencing lingering symptoms; and tallied the economic effects of the resulting lost wages.

Comments closed

Tackling the ‘silent pandemic’: breakthrough study puts first long COVID treatment on horizon

Researchers have shown a new drug compound can prevent long COVID symptoms in mice – a landmark finding that could lead to a future treatment for the debilitating condition.

The world-first study found mice treated with the antiviral compound, developed by a multidisciplinary research team at WEHI, were protected from long term brain and lung dysfunction – key symptoms of long COVID.

Researchers hope the unprecedented results could lead to clinical trials and the first treatment for the disease in the future.

Comments closed